U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. Paul Rogers
  1. Science & Research (NCTR)

Paul Rogers Ph.D.
Leadership Role

Biostatistician — Division of Bioinformatics and Biostatistics

Headshot of Dr. Paul Rogers

Paul Rogers, Ph.D.
(870) 543-7121
NCTRResearch@fda.hhs.gov  

Back to NCTR Principal Investigators page

 About  |  Publications

Background

Paul Rogers is a biostatistician in the Division of Bioinformatics and Biostatistics at FDA’s National Center for Toxicological Research (NCTR). Before joining FDA, Dr. Rogers spent 18 years at the Federal Aviation Administration’s national toxicology research laboratory in Oklahoma City. His interests include computational epidemiology, high-performance computing, generalized estimating equations, scientific information systems, research database applications, statistical software, and communication of risks.

Research Interests

Dr. Rogers's expertise and experience are focused on computational epidemiology, high-performance computing, generalized estimating equations, scientific information systems, geographic information systems (GIS), research database applications, and statistical software. In addition, his interests include population-based research, pharmacoepidemiology, rare-event modeling, and applications of GIS on epidemiology. Currently, he is conducting research with Long Short-Term Memory Networks and Intensive Care Unit vital sign data.

Professional Societies/National and International Groups

American Statistical Association
Member
2014 – Present

 

Select Publications/Reports

Investigation of Sex-Based Differences in the Immunotoxicity of Silver Nanoparticles.
Canup B., Rogers P., Paredes A., Manheng W., Lyn-Cook B., and Fahmi T. 
Nanotoxicology. 2024, 1-26. doi:10.1080/17435390.2024.2323070.

RxNorm for Drug Name Normalization: A Case Study of Prescription Opioids in the FDA Adverse Events Reporting System.
Le H., Chen R., Harris S., Fang H., Lyn-Cook B., Hong H., Ge W., Rogers P., Tong W., and Zou W.
Front Bioinform. 2024, 3:1328613. doi: 10.3389/fbinf.2023.1328613. PMID: 38250436; PMCID: PMC10796552.

Controlling for Confounding in Complex Survey Machine Learning Models to Assess Drug Safety and Risk.
Rogers P.B.
In: Hong H (Ed.) Machine Learning and Deep Learning in Computational Toxicology. 2023, pp. 355-374, Springer International Publishing.

A Systematic Analysis and Data Mining of Opioid-Related Adverse Events Submitted to the FAERS Database.
Le H., Hong H., Ge W., Francis H., Lyn-Cook B., Hwang Y.T., Rogers P., Tong W., and Zou W. 
Experimental Biology and Medicine. 2023, 0(0):15353702231211860. doi:10.1177/15353702231211860.

Translational Research for Identifying Potential Early-Stage Prostate Cancer Biomarkers.
Nakamura N., Rogers P.B., Eggerson R., Post S.R., and Davis R.
Cancer Genomics Proteomics. 2023, 20(1):1-8. doi:10.21873/cgp.20359.

Assessment of a Modified Sandwich Estimator for Generalized Estimating Equations with Application to Opioid Poisoning in MIMIC-IV ICU Patients.
Rogers P.B. and Stoner J.A.
Stats. 2021, 4(3), 650-664. https://doi.org/10.3390/stats4030039.

Medical Information Mart for Intensive Care: A Foundation for the Fusion of Artificial Intelligence and Real-World Data.
Rogers P.B., Wang D., and Lu Z.
Front. Artif. Intell. 2021, https://doi.org/10.3389/frai.2021.691626.

The Use of a Poisson Regression to Evaluate Antihistamines and Fatal Aircraft Mishaps in IMC.
Gildea K., Hileman C., Rogers P.B., and Salazar G.
Aerosp Med Hum Perform. 2018, 89(4):389-395. doi: 10.3357/AMHP.4828.2018.

Pilots Using Selective Serotonin Reuptake Inhibitors Compared to Other Fatally Injured Pilots.
Rogers P.B., Hileman C., Guillermo G., Cliburn K., Paskoff L., Hathaway W., Gildea K., and Villala V.H.T.
Accid Anal Prev. 2017, 107:86-91. doi: 10.1016/j.aap.2017.07.023. Epub 2017 Aug.12.

Development of a Geographic Information System for Risk-Informed Decision Making in Aerospace Medicine.
Paskoff L. and Rogers P.B.
Aerosp Med Hum Perform. 2016, 87(11):972-975. doi: 10.3357/AMHP.4751.2016.

Ethanol and Drugs Found in Civil Aviation Accident Pilot Fatalities, 1989-2013.
Chaturvedi A.K., Craft K.J., Hickerson J.S., and Rogers P.B.
Aerosp Med Hum Perform. 2016, 87(5):470-6. doi: 10.3357/AMHP.4490.2016.

Risk Assessment in the US Pilot Population from 1983-2005; Diabetes Prevalence and Flight Safety.
Rogers P.B., Verroneau S., and Forster E.
Office of Aerospace Medicine. 2015, DOT/FAA/AM-15/5.

Modification of the Sandwich Estimator in Generalized Estimating Equations with Correlated Binary Outcomes in Rare Event and Small Sample Settings.
Rogers P.B.  and Stoner J.A.
Am J Appl Math Stat. 2015, 3(6):243-251. doi: 10.12691/ajams-3-6-5.

The +Gz Recovery of Consciousness Curve.
Whinnery T., Forster E., and Rogers P.
Extrem Physiol Med. 2014, 3:9. doi: 10.1186/2046-7648-3-9. eCollection 2014.

Toxicological Findings in Fatally Injured Pilots of 979 Amateur-Built Aircraft Accidents.
Chaturvedi A.K., Craft K.J., Hickerson J.S., Rogers P.B., and Soper J.W.
Aviat Space Environ Med. 2013, 84(2):134-41. doi: 10.3357/asem.3285.2013.

Increased Cannabinoids Concentrations Found in Specimens from Fatal Aviation Accidents Between 1997 and 2006.
Canfield D., Dubowski K., Whinnery J., Lewis R., Ritter R., and Rogers P.
Forensic Sci Int. 2010, 197(1-3):85-8. doi: 10.1016/j.forsciint.2009.12.060. Epub 2010 Jan 13.

Evaluating Probabilistic Risk Assessment Methodology for use in the Medical Certification of Airmen.
Rogers P.B.
Aviat Space Environ Med. 2009, 80(10):904-5. doi: 10.3357/asem.21008.2009.

The FAA’s Postmortem Forensic Toxicology Proficiency-Testing Program; the Second Seven Years.
Chaturvedi A.K., Craft C.J., Cardona P.S., Rogers P.B., and Canfield D.V.
J Anal Toxicol. 2009, 33(4):229-36. doi: 10.1093/jat/33.4.229.

An Analysis of the U.S. Pilot Population From 1983-2005: Evaluating the Effects of Regulatory Change.
Rogers P., Veronneau S., Peterman C., Whinnery J., and Forster E.M.
Office of Aerospace Medicine. 2009, DOT/FAA/AM-09/9.

Development of an Aeromedical Scientific Information System for Aviation Safety.
Peterman C., Rogers P., Veronneau S., and Whinnery J.
Office of Aerospace Medicine. 2008, DOT/FAA/AM-08/1.

Contact Information
Paul Rogers
(870) 543-7121
Expertise
Expertise
Approach
Domain
Technology & Discipline
Toxicology
Back to Top